Ab Corporate Bond ETF (EYEG)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.

BillionerOfKing
BillionerOfKing Jan. 27 at 3:28 AM
$EYEG Current Stock Price: $35.91
0 · Reply
AlphaTuna
AlphaTuna Oct. 28 at 12:05 AM
Highest Volume Rated ETFs Per 10/27/2025’s Close: 1 – $LFAI 2 – $GVUS 3 – $EYEG 4 – $ABLS 5 – $IDEC 6 – $NDEC 7 – $QCML 8 – $NXTI 9 – $XHLF 10 – $GSID https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-10-27-2025/
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 9 at 6:50 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:34 AM
$EYEG KIO-301 looks promising. Orphan drug designation is huge. Adding small position to watch clinical trial progress. high-quality article: https://beyondspx.com/article/kiora-pharmaceuticals-inc-kprx-navigating-the-ophthalmic-landscape-with-innovation-and-resilience
0 · Reply
PenkeInvesting
PenkeInvesting Dec. 20 at 2:26 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
AlphaTuna
AlphaTuna Nov. 25 at 11:47 PM
Highest Volume Rated ETFs Per 11/25/2024’s Close: 1 – $PBMY 2 – $PBSE 3 – $UNIY 4 – $BCIL 5 – $EYEG 6 – $MAPP 7 – $GVUS 8 – $JHDV 9 – $WBND 10 – $GGUS https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-11-25-2024/
0 · Reply
PenkeInvesting
PenkeInvesting Nov. 2 at 12:44 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
PenkeInvesting
PenkeInvesting Aug. 3 at 6:00 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #EYEG #nasdaq #tradingsignals #technicalanalysis
0 · Reply
ChartMill
ChartMill Dec. 17 at 3:17 PM
Gap up for $EYEG today. https://www.chartmill.com/stock/stock-screener?v=3&f=s_gup,p_pg10,v1_50b500,exch_us&utm_source=Gap_Up&utm_medium=stocktwits&utm_campaign=screen
0 · Reply
Latest News on EYEG
Bonds still bouncing along

Sep 9, 2024, 4:55 PM EDT - 1 year ago

Bonds still bouncing along

CPLS HYFI JPST TLT USHY YEAR

AllianceBernstein Launches Five New Active ETFs

Dec 13, 2023, 7:30 AM EST - 2 years ago

AllianceBernstein Launches Five New Active ETFs

AB BUFC CPLS TAFL TAFM

EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc.

Oct 26, 2021, 7:00 AM EDT - 5 years ago

EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc.

EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 9, 2021, 4:15 PM EDT - 5 years ago

EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation

Sep 8, 2021, 6:55 AM EDT - 5 years ago

EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation

EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update

Aug 12, 2021, 4:15 PM EDT - 5 years ago

EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update

EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 11, 2021, 4:15 PM EDT - 5 years ago

EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 10, 2021, 6:55 AM EDT - 5 years ago

EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D.

Jul 26, 2021, 4:15 PM EDT - 5 years ago

EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D.

EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study

Jun 14, 2021, 6:55 AM EDT - 5 years ago

EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study

EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021, 4:15 PM EDT - 5 years ago

EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update

EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors

Apr 1, 2021, 6:55 AM EDT - 5 years ago

EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors

EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update

Mar 25, 2021, 4:15 PM EDT - 5 years ago

EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update

EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation

Feb 1, 2021, 6:55 AM EST - 5 years ago

EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation

EyeGate Enters Into Agreement for $8.0 Million Private Placement

Jan 6, 2021, 6:55 AM EST - 5 years ago

EyeGate Enters Into Agreement for $8.0 Million Private Placement

EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma

Dec 21, 2020, 6:55 AM EST - 6 years ago

EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma

EyeGate shares jump on data for eye treatment data

Nov 22, 2019, 8:37 AM EST - 7 years ago

EyeGate shares jump on data for eye treatment data

BillionerOfKing
BillionerOfKing Jan. 27 at 3:28 AM
$EYEG Current Stock Price: $35.91
0 · Reply
AlphaTuna
AlphaTuna Oct. 28 at 12:05 AM
Highest Volume Rated ETFs Per 10/27/2025’s Close: 1 – $LFAI 2 – $GVUS 3 – $EYEG 4 – $ABLS 5 – $IDEC 6 – $NDEC 7 – $QCML 8 – $NXTI 9 – $XHLF 10 – $GSID https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-10-27-2025/
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 9 at 6:50 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:34 AM
$EYEG KIO-301 looks promising. Orphan drug designation is huge. Adding small position to watch clinical trial progress. high-quality article: https://beyondspx.com/article/kiora-pharmaceuticals-inc-kprx-navigating-the-ophthalmic-landscape-with-innovation-and-resilience
0 · Reply
PenkeInvesting
PenkeInvesting Dec. 20 at 2:26 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
AlphaTuna
AlphaTuna Nov. 25 at 11:47 PM
Highest Volume Rated ETFs Per 11/25/2024’s Close: 1 – $PBMY 2 – $PBSE 3 – $UNIY 4 – $BCIL 5 – $EYEG 6 – $MAPP 7 – $GVUS 8 – $JHDV 9 – $WBND 10 – $GGUS https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-11-25-2024/
0 · Reply
PenkeInvesting
PenkeInvesting Nov. 2 at 12:44 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #RsiOversold #NASDAQ
0 · Reply
PenkeInvesting
PenkeInvesting Aug. 3 at 6:00 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of AB Corporate Bond ETF. Is that bullish or bearish? $EYEG #EYEG #nasdaq #tradingsignals #technicalanalysis
0 · Reply
ChartMill
ChartMill Dec. 17 at 3:17 PM
Gap up for $EYEG today. https://www.chartmill.com/stock/stock-screener?v=3&f=s_gup,p_pg10,v1_50b500,exch_us&utm_source=Gap_Up&utm_medium=stocktwits&utm_campaign=screen
0 · Reply